植物來源藥物市場：依原料、劑型、治療用途及地區分類。

Botanical and Plant Derived Drugs Market, By Source, By Dosage Form, By Therapeutic Application, By Geography

出版日期: 2026年05月26日 | 出版商:

Coherent Market Insights | 英文 252 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，植物來源市場規模將達到526億美元，到2033年將達到807億美元。預計從2026年到2033年，該市場將以6.3%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	526億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.30%	2033年市場規模預測：	807億美元

植物來源藥物含有從植物中提取的活性成分。植物來源藥物是植物材料的混合物，包括整株植物、植物的各個部位、真菌或藻類。雖然植物長期以來一直被用作藥物的原料，但人們對合成藥物副作用的擔憂導致人們越來越傾向於選擇植物來源藥物而非合成藥物。

此外，植物藥與傳統藥物一樣，都需要經過臨床評估以驗證其安全性和有效性。醫用大麻的合法化預計也將促進植物藥及植物來源藥物市場的成長。

市場動態

由於醫用大麻合法化，預計全球植物性及植物來源藥品市場在預測期內將顯著成長。捷克共和國於2013年將醫用大麻合法化，阿根廷和智利則於2015年效法。此外，2016年標誌著美國大麻合法化進程的轉捩點，一些州將醫用大麻合法化。

因此，許多製造商正致力於醫用大麻的研發，以推出新藥。例如，GW Pharmaceuticals公司正在研發的藥物Epidiolex，其主要成分為大麻二酚（CBDV），並計劃在2016年在新南威爾斯和昆士蘭州政府的支持下，用於治療難治性癲癇的臨床試驗。

此外，慢性病的日益增加也推動了植物來源的發展，因為肺癌是東亞、南亞和東南亞地區的主要死因。根據癌症地圖集（Cancer Atlas）的統計數據，該地區佔世界人口的56%，卻佔全球整體癌症病例總數的44%。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球植物來源市場的主要參與者進行了分析：公司概況、財務績效、產品系列、企業發展地理區域、分銷策略、關鍵發展和整體策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、政府舉措、市場擴張和行銷策略做出明智的決策。
這份《全球植物來源市場報告》旨在為業內廣泛的相關人員提供參考，包括投資者、產品製造商、經銷商、供應商、研究和諮詢公司、新參與企業和金融分析師。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 52.6 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.30%	2033 Value Projection:	USD 80.7 Bn

Botanical and plant derived drugs contain active ingredients derived from plants. The botanical drug is a mixture of plant materials that include whole plant, part of plants, fungi or algae. Plants have been used as a source of medicine since past, owing to side effects caused due to consumption of synthetic drugs the botanical and plant derived drugs are preferred over the synthetic drugs.

Furthermore, the botanical drugs are clinically evaluated for safety and efficacy just as conventional drugs. Besides, this legalization of medical cannabis is also expected to foster growth of the botanical and plant derived drugs market.

Market Dynamics

The global botanical and plant derived drugs market is projected to witness significant growth over the forecast period, owing to legalization of medical cannabis. Medical cannabis was legalized in the Czech Republic, in 2013, Argentina and Chile in 2015, and in 2016, marijuana legalization in America reached a tipping point, as the medical marijuana became legal in some of the states.

Hence, many manufacturers are focused on research and development on medical cannabis to launch new drugs. For instance, one of the drug by GW Pharmaceuticals, Epidiolex consists of cannabidivarin (CBDV) is in developmental process, which will be used in clinical trials for treatment resistant epilepsy, supported by NSW and Queensland government in 2016.

Furthermore, increasing number of chronic disease supports the growth of botanical and plant derived drugs, as lung cancer accounts for the leading cause of death in the Eastern, Southern and Southeastern Asia. The region holds for 56% of the world's population and contributes to 44% of the total cancer cases worldwide according to the statistics mentioned in the Cancer Atlas.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global botanical and plant derived drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Bayer Healthcare, GlaxoSmithKline, Pfizer, Inc. Sanofi, Actelion Pharmaceuticals, Aimil Pharmaceuticals, Allergan, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Concordia Pharmaceuticals, GW Pharmaceuticals, LEO Pharma, MEDICAGO, and Merck.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, market expansion, and marketing tactics.
The global botanical and plant derived drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for botanical and plant derived drugs market, research and consulting firms, new entrants, and financial analysts.

Market Segmentation

By Source (Revenue, USD Bn, 2021-2033)
- Plant
- Algae
- Macroscopic fungi
- Others
By Dosage Form (Revenue, USD Bn, 2021-2033)
- Pills
- Tablets
- Capsules
- Injection
By Therapeutic Application (Revenue, USD Bn, 2021-2033)
- Central Nervous System
- Cardiovascular Diseases
- Infectious Diseases
- Respiratory Diseases
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- South Africa
- Central Africa
Key Players
- Bayer Healthcare
- GlaxoSmithKline
- Pfizer, Inc.
- Sanofi
- Actelion Pharmaceuticals
- Aimil Pharmaceuticals
- Allergan
- AstraZeneca
- Boehringer Ingelheim
- GW Pharmaceuticals

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Global Botanical and Plant Derived Drugs Market, By Source
- Global Botanical and Plant Derived Drugs Market, By Dosage Form
- Global Botanical and Plant Derived Drugs Market, By Therapeutic Application
- Global Botanical and Plant Derived Drugs Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Recent product launches
Regulatory Scenario
Awareness initiatives
PEST Analysis
PORTER's Analysis
Epidemiology

4. Global Botanical and Plant Derived Drugs Market, By Source, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Plant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Algae
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Macroscopic fungi
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

5. Global Botanical and Plant Derived Drugs Market, By Dosage Form, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

6. Global Botanical and Plant Derived Drugs Market, By Therapeutic Application, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Central Nervous System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Respiratory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

7. Global Botanical and Plant Derived Drugs Market, By Regions, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, By Region, 2022 - 2033
- Regional Trends
North America
- Market Size and Forecast, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Countries, 2021 - 2033, (US$ Billion)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Countries, 2021 - 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Latin America
- Market Size and Forecast, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Countries, 2021 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Asia Pacific
- Market Size and Forecast, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Countries, 2021 - 2033, (US$ Billion)
  - China
  - India
  - Japan
  - Australia
  - ASEAN
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Countries, 2021 - 2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Countries, 2021 - 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Bayer Healthcare
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- GlaxoSmithKline
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Pfizer, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sanofi
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Actelion Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Aimil Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Allergan
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- AstraZeneca
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Boehringer Ingelheim
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- GW Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
  - Analyst Views